These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Determination of naltrexone and its major metabolite, 6-beta-naltrexol, in human plasma using liquid chromatography with electrochemical detection.
    Author: Davidson AF, Emm TA, Pieniaszek HJ.
    Journal: J Pharm Biomed Anal; 1996 Sep; 14(12):1717-25. PubMed ID: 8887719.
    Abstract:
    A sensitive and specific high-performance liquid chromatographic method with electrochemical detection was developed for the simultaneous determination of naltrexone and its major metabolite, 6-beta-naltrexol, in human plasma. After alkalinizing 2 ml plasma samples with pH 9 sodium carbonate buffer, naltrexone and 6-beta-naltrexol were extracted into dichloromethane and then back-extracted into 0.017 M phosphoric acid. A portion of the acid extract was chromatographed on a YMC phenyl column using a mobile phase of methanol-phosphoric acid (50 mM) (20:80, v/v) (pH* 3.2) at a flow-rate of 1.2 ml min 1. Quantification was performed using an ESA Coulometric electrochemical detector. Acceptable intra-day and assay precision (RSD < 10%) and accuracy (< 16%) for both compounds were observed over concentration ranges of 0.25-50.0 ng ml-1 for naltrexone and 0.5-100 ng ml-1 for 6-beta-naltrexol. No degradation of either naltrexone or 6-beta-naltrexol was observed in frozen human plasma stored at -20 degrees C over an 8 month period. The method is sufficiently sensitive and selective to quantify plasma concentrations of naltrexone and 6-beta-naltrexol after oral doses of 50 mg of naltrexone to healthy subjects or alcoholic patients.
    [Abstract] [Full Text] [Related] [New Search]